Co-creation of Patient Engagement Quality Guidance and Quality Criteria for Medicines Development: An International Multi-stakeholder Initiative

K Deane; Søren Eik Skovlund; B Nafria; L Delbecque; OV Gorbenko; C Pakarinen; N Brooke; AM Hamoir; PFMD Patient Engagement Meta-framework Co-creation Team; Søren Eik Skovlund

Co-creation of Patient Engagement Quality Guidance and Quality Criteria for Medicines Development: An International Multi-stakeholder Initiative

K Deane, Søren Eik Skovlund, B Nafria, L Delbecque, OV Gorbenko, C Pakarinen, N Brooke, AM Hamoir, PFMD Patient Engagement Meta-framework Co-creation Team, Søren Eik Skovlund (Member of study group)

Research output: Contribution to conference without publisher/journal › Poster › Research › peer-review

63 Downloads (Pure)

Abstract

The value and necessity of engaging patients during the development and lifecycle of medicines is increasingly recognised and many discrete initiatives are underway or planned.

Though complementary, these separate activities have resulted in a fragmented patient engagement (PE) landscape. Investment in a holistic, integrated and sustainable initiative is required to cover the entire medicines lifecycle and to connect stakeholders across geographies.

This poster focuses on the development of the PE Quality Guidance and identification of good practice examples.

Original language	English
Publication date	2018
Number of pages	1
Publication status	Published - 2018
Event	ISPOR 2018 - , Spain Duration: 10 Nov 2018 → 14 Nov 2018 https://www.ispor.org/Event/index/2018barcelona

Conference

Conference	ISPOR 2018
Country/Territory	Spain
Period	10/11/2018 → 14/11/2018
Internet address	https://www.ispor.org/Event/index/2018barcelona

Keywords

Co-creation
Patient engagement
Medicine

Access to Document

Deane, Skovlund et al. (2018) ISPOR posterFinal published version, 1.32 MB

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Deane, K., Skovlund, S. E., Nafria, B., Delbecque, L., Gorbenko, OV., Pakarinen, C., Brooke, N., Hamoir, AM., PFMD Patient Engagement Meta-framework Co-creation Team, & Skovlund, S. E. (2018). Co-creation of Patient Engagement Quality Guidance and Quality Criteria for Medicines Development: An International Multi-stakeholder Initiative. Poster presented at ISPOR 2018, Spain.

@conference{0d556294e6234403b1c94e2ddf004e20,

title = "Co-creation of Patient Engagement Quality Guidance and Quality Criteria for Medicines Development: An International Multi-stakeholder Initiative",

abstract = "The value and necessity of engaging patients during the development and lifecycle of medicines is increasingly recognised and many discrete initiatives are underway or planned.Though complementary, these separate activities have resulted in a fragmented patient engagement (PE) landscape. Investment in a holistic, integrated and sustainable initiative is required to cover the entire medicines lifecycle and to connect stakeholders across geographies.This poster focuses on the development of the PE Quality Guidance and identification of good practice examples.",

keywords = "Co-creation, Patient engagement, Medicine",

author = "K Deane and Skovlund, {S{\o}ren Eik} and B Nafria and L Delbecque and OV Gorbenko and C Pakarinen and N Brooke and AM Hamoir and {PFMD Patient Engagement Meta-framework Co-creation Team} and Skovlund, {S{\o}ren Eik}",

year = "2018",

language = "English",

note = "ISPOR 2018 ; Conference date: 10-11-2018 Through 14-11-2018",

url = "https://www.ispor.org/Event/index/2018barcelona",

}

TY - CONF

T1 - Co-creation of Patient Engagement Quality Guidance and Quality Criteria for Medicines Development

T2 - ISPOR 2018

AU - Deane, K

AU - Skovlund, Søren Eik

AU - Nafria, B

AU - Delbecque, L

AU - Gorbenko, OV

AU - Pakarinen, C

AU - Brooke, N

AU - Hamoir, AM

AU - PFMD Patient Engagement Meta-framework Co-creation Team

A2 - Skovlund, Søren Eik

PY - 2018

Y1 - 2018

N2 - The value and necessity of engaging patients during the development and lifecycle of medicines is increasingly recognised and many discrete initiatives are underway or planned.Though complementary, these separate activities have resulted in a fragmented patient engagement (PE) landscape. Investment in a holistic, integrated and sustainable initiative is required to cover the entire medicines lifecycle and to connect stakeholders across geographies.This poster focuses on the development of the PE Quality Guidance and identification of good practice examples.

AB - The value and necessity of engaging patients during the development and lifecycle of medicines is increasingly recognised and many discrete initiatives are underway or planned.Though complementary, these separate activities have resulted in a fragmented patient engagement (PE) landscape. Investment in a holistic, integrated and sustainable initiative is required to cover the entire medicines lifecycle and to connect stakeholders across geographies.This poster focuses on the development of the PE Quality Guidance and identification of good practice examples.

KW - Co-creation

KW - Patient engagement

KW - Medicine

UR - https://myisporbarcelona.zerista.com/poster?owner=other&owner_id=2332070&terms=Co-creation+of+Patient+Engagement+Quality+Guidance+and+Quality+Criteria+for+Medicines+Development&poster_page=1&poster_order=name

M3 - Poster

Y2 - 10 November 2018 through 14 November 2018

ER -

Co-creation of Patient Engagement Quality Guidance and Quality Criteria for Medicines Development: An International Multi-stakeholder Initiative

Abstract

Conference

Keywords

Access to Document

AUB Link

Other files and links

Fingerprint

Cite this